|
Why License?
Development of new pharmaceutical and biotech projects can be an extremely costly and time-consuming process. Many new drug candidates and platforms are the result of innovative work in academic institutions or small startups, however these institutions rarely have the funding available to carry a candidate through clinical trials and commercialization. This requirement creates the need for licensing partnerships with larger pharmaceutical companies, which can afford to take on the financial burden. |
Archives
May 2020
Topics
All
|